In a large European cohort of PCa patients treated with radical prostatectomy, it has been demonstrated that patients with PSA-DT < 2 years and pathological ISUP grade group > 3, which identifies a subgroup at high risk of biochemical recurrence, are associated with an increased risk of metastatic progression and higher cancer-specific mortality. The gene discussed is KLK3; the disease is posterior cortical atrophy.